Literature DB >> 6091713

The effects of ranitidine on pituitary-thyroid function.

K R Hine, J S Harrop, M R Hopton, G K Holmes, H L Matthews.   

Abstract

Although several studies have examined the effects of cimetidine on pituitary-thyroid function, few have investigated ranitidine in this respect. We found no changes in thyroid-stimulating-hormone (TSH) or prolactin responses to TSH-releasing-hormone (TRH) in 10 patients with peptic ulcer disease given oral ranitidine. Serum total and free thyroxine (TT4 and FT4) concentrations declined slightly, whereas total and free triiodothyronine (TT3 and FT3) increased slightly following ranitidine. None of these changes achieved statistical significance. Both the ratio of TT4/TT3 and FT4/FT3, however, declined (P less than 0.05) following ranitidine. Thus ranitidine may have a minor influence on peripheral deiodination of thyroxine but has little effect on hormone production from the thyroid gland. The diagnostic value of biochemical tests of thyroid function is not seriously compromised in patients receiving ranitidine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091713      PMCID: PMC1463608          DOI: 10.1111/j.1365-2125.1984.tb02512.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  Letter: Breast changes in males on cimetidine.

Authors:  W H Hall
Journal:  N Engl J Med       Date:  1976-10-07       Impact factor: 91.245

2.  Gynaecomastia with cimetidine.

Authors:  G F Delle Fave; G Tamburrano; L De Magistris; C Natoli; M L Santoro; R Carratu; A Torsoli
Journal:  Lancet       Date:  1977-06-18       Impact factor: 79.321

3.  Cimetidine, an H2-antihistamine, stimulates prolactin secretion in man.

Authors:  H E Carlson; A F Ippoliti
Journal:  J Clin Endocrinol Metab       Date:  1977-08       Impact factor: 5.958

4.  Evidence for a thyrotropin inhibitory effect of histamine in man.

Authors:  P May; G Schneider; M Ayub; S Chandiok; N Ertel; W Giglio
Journal:  J Clin Endocrinol Metab       Date:  1979-10       Impact factor: 5.958

5.  Effects of cimetidine on prolactin, LH, and sex steroid secretion in male and female volunteers.

Authors:  H G Bohnet; M Greiwe; J P Hanker; C Aragona; H P Schneider
Journal:  Acta Endocrinol (Copenh)       Date:  1978-07

6.  Prolactin responses to cimetidine.

Authors:  W L Burland; R I Gleadle; R M Lee; D Rowley-Jones; G V Groom
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

7.  Cimetidine effects on prolactin release and production.

Authors:  S G Barber; A M Hoare
Journal:  Horm Metab Res       Date:  1979-03       Impact factor: 2.936

8.  Gynaecomastia associated with cimetidine.

Authors:  R W Spence; L R Celestin
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

9.  Hypothalamic-pituitary-gonadal dysfunction in men using cimetidine.

Authors:  D H Van Thiel; J S Gavaler; W I Smith; G Paul
Journal:  N Engl J Med       Date:  1979-05-03       Impact factor: 91.245

10.  Influence of histamine- and 5-hydroxytryptamine-containing thyroid mast cells on thyroid blood flow and permeability in the rat.

Authors:  A Melander; U Westgren; F Sundler; L E Ericson
Journal:  Endocrinology       Date:  1975-11       Impact factor: 4.736

View more
  2 in total

Review 1.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

Review 2.  Adverse reactions and interactions with H2-receptor antagonists.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.